Tenderwize
Retour à la recherche

Supply of heparins and antithrombotic lock solutions

HUmani SC·Charleroi, Belgium·EUR 2.4M·Expired · Jul 28, 2026·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
High value
Titre original de l'avis

Belgium – Pharmaceutical products – FOURNITURE D'HEPARINES ET DE VERROUS ANTITHROMBOTIQUES DES CATHETERS POUR HEMODIALYSE 2026-2030

63/100

Score d'opportunité

Needs reviewHigh complexity
SuppliesFrameworkExpired
Pourquoi ce score ?

Opportunité

63 / 100

Complexité

68 / 100

Facteurs de risque

The structured data deadline time (08:30 UTC) and XML notice time (10:30 local time) are consistent in substance but di...

A document URL is provided, but only the XML notice text was extracted; the full procurement documents were not analyze...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
HUmani SC
Pays
Belgique
CPV
33600000 - Pharmaceutical products
Date limite
Jul 28, 2026
Valeur estimée
EUR 2.4M

Aperçu

Moderate opportunity

Faits clés

  • EUR 2.4M estimated value
  • Framework procurement
  • Supplies contract
  • 3 lots
  • Duration until Sep 2030
  • Supply of heparins and antithrombotic catheter locks for hemodialysis treatments.
  • Framework agreement for pharmaceutical supplies.
Afficher le résumé complet

Open supply framework agreement for pharmaceutical products: heparins and antithrombotic catheter locks for hemodialysis, awarded by HUmani SC for its pharmacies and those of VIVALIA. Three lots are indicated in the XML notice, but the structured data only fully describes lots 1-3 with lot-specific framework maximum values and award criteria. Submission is electronic and the deadline is 2026-07-28 08:30 UTC in the structured data (XML shows 10:30 local time).

Risques

The structured data deadline time (08:30 UTC) and XML notice time (10:30 local time) are consistent in substance but di...

A document URL is provided, but only the XML notice text was extracted; the full procurement documents were not analyze...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • The procedure is open.
  • The contract is a framework agreement.

Administrative

  • Electronic submission is required.

Critères d'attribution

Lot 1

Price, weight 100, code poi-exa — 100%

Lot 2

Price, weight 55, code poi-exa — 55%Quality of proposed products, weight 35, code poi-exa — 35%Quality criterion, weight 10, code poi-exa — 10%

Lot 3

Price, weight 50, code poi-exa — 50%Quality of proposed products, weight 48, code poi-exa — 48%Quality criterion, weight 2, code poi-exa — 2%

Acheteur

Localisation

Charleroi, BEL

Profil acheteur

Ouvrir le profil

Identifiant

BE 216.377.108.

Activité

Health

Lots (3)

LOT-0001

Unfractionated Heparin 5,000 IU/ml

Supply of unfractionated heparin 5,000 IU/ml for hemodialysis-related use. Framework agreement; place of performance explicitly listed as Chimay. The lot-specific framework maximum value is EUR 634,620.

SuppliesFrameworkEU fundedElectronic submission

EUR 634.6k

Valeur estimée

Localisation

Chimay, Belgium

Durée

Sep 2026 - Sep 2030

Catégorie

Pharmaceutical products

Critères d'attribution

Price

Date limite

Expired Jul 28, 2026

LOT-0002

Enoxaparin Syringe (Low Molecular Weight Heparins)

Supply of enoxaparin syringe products. Framework agreement; place of performance explicitly listed as Montigny-le-Tilleul. The lot-specific framework maximum value is EUR 1,517,199.12.

SuppliesFrameworkEU fundedElectronic submission

EUR 1.5M

Valeur estimée

Localisation

Montigny-le-Tilleul, Belgium

Durée

Sep 2026 - Sep 2030

Catégorie

Pharmaceutical products

Critères d'attribution

Best price-quality ratio

Date limite

Expired Jul 28, 2026

LOT-0003

Trisodium Citrate Lock Solution (Pre-filled Syringe)

Supply of trisodium citrate lock solution in pre-filled syringes. Framework agreement; place of performance explicitly listed as Lodelinsart. The lot-specific framework maximum value is EUR 280,350.

SuppliesFrameworkEU fundedElectronic submission

EUR 280.4k

Valeur estimée

Localisation

Lodelinsart, Belgium

Durée

Sep 2026 - Sep 2030

Catégorie

Pharmaceutical products

Critères d'attribution

Best price-quality ratio

Date limite

Expired Jul 28, 2026

Détails de la procédure

Date de publication
29 Jun 2026
Langues
French

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
448028-2026

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.

Dec 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30